4.7 Article

Ligand pathways in estrogen-related receptors

期刊

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
卷 41, 期 5, 页码 1639-1648

出版社

TAYLOR & FRANCIS INC
DOI: 10.1080/07391102.2022.2027818

关键词

Estrogen-related receptor; ERR; molecular dynamics; metadynamics; pathways; nuclear receptors; tunnels; channels

向作者/读者索取更多资源

ERR alpha, ERR beta, and ERR gamma are nuclear receptors that regulate metabolic processes in various tissues. They have been implicated as drug targets for important indications. This study used molecular dynamics and metadynamics simulations to investigate the ligand pathways of these receptors, revealing their distribution and their role in ligand translocation.
The three subtypes of estrogen-related receptors ERR alpha, ERR beta, and ERR gamma are nuclear receptors mediating metabolic processes in various tissues such as the skeletal muscle, fat tissue, bone, and liver. Although the knowledge on their physiological ligands is limited, they have been implicated as drug targets for important indications including diabetes, cardiovascular diseases, and osteoporosis. As in other nuclear receptors, their ligand binding pocket is buried within the core of the receptor and connected to its surrounding by ligand pathways. Here, we investigated these pathways with conventional molecular dynamics as well as metadynamics simulations to reveal their distribution and their capability to facilitate ligand translocation. Dependent on the ERR subtype and the conformational state of the receptor, we could detect different pathways to be favored. Overall, the results suggested pathways IIIa and IIIb to be favored in the agonistic conformation, while antagonists preferred pathways I, II, and V. Along the pathways, the ligands passed different gating mechanisms of the receptor, including groups of protein residues as well as whole secondary structure elements, to leave the binding site. Even though these pathways are suggested to influence ligand specificity of the receptors and their elucidation might advance rational drug design, they have not yet been studied in ERRs. Communicated by Ramaswamy H. Sarma

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据